Veterinary continuous glucose monitor to relaunch in 2026

The GluCurve Pet Continuous Glucose Monitor (CGM) may be returning to veterinary clinics in Canada and the US following internal manufacturing testing that showed accuracy comparable to the veterinary Blood Glucose Meter. The device is scheduled to relaunch in Canada in January 2026, and is planned to launch in the US in the second quarter of 2026, according to ALR Technologies SG Ltd, whose animal health division is launching the monitor.

GluCurve is a monitoring system for cats and dogs with diabetes. The device is the first diabetic monitoring system built specifically for veterinary use on these animals, said ALR Technologies in a press release announcing the tool’s relaunch.¹ The system works by attaching a continuous glucose monitor sensor to the pet. The sensor then records glucose readings every 3 minutes for up to 2 weeks. The readings appear on a smartphone app for the pet owner and are also sent to an online portal that veterinarians can use to monitor patients and adjust insulin dosing in person or remotely.

According to Joe Stern, head of Animal Health at ALR Technologies, the potential demand for GluCurve is high, estimated to reach up to 300,000 units a year in Canada, up to 3 million units a year in the US, and up to 3 million units a year in Europe. “You cannot prick the finger of a cat or dog to check blood sugar as you would with a human, and even when you can draw blood from their ear, paw, or vein, a spot check of this nature does not provide the data needed to properly dose insulin or see trends as a CGM would,” Stern said in a company press release.¹ “We believe this is why we have received so much interest and demand for the GluCurve Pet CGM from veterinarians, pet owners, and animal health companies, because there is a desperate need for a holistic product like ours to manage diabetic pets.”

Stern said the company has spent the past 2 years working with a manufacturing partner in Shenzhen, China, on the production of GluCurve. The partnership, he said, not only covers the animal device but is also intended to support the development of a CGM monitor for humans. With the manufacturing lines now in place at a Foxconn facility, Stern said the company is nearing the launch of a redesigned GluCurve.

According to ALR Technologies, the company has successfully completed internal testing of their GluCurve device. The results were comparable to the blood glucose monitor most commonly used in cats and dogs, which many veterinarians view as the gold standard. A separate, independent study is set to begin in mid-December to confirm GluCurve’s efficacy, comparing the device’s readings with those from the leading veterinary blood glucose meter and a chemistry analyzer.

The device is planned to relaunch in the United States in the early second quarter of 2026. Thereafter, it will be launched globally across Europe, Australia, Asia, South America, and the rest of the world.

Currently, Adapet has a CGM system for pets with also its own mobile app. The system also sends readings to a veterinary web portal. The device lasts up to 9 days, but the company is working on making changing to the system so that it can last up to 14 days, Dustin Brietzke, director of operations at Adapet, said in an interview this fall.²

References

1. Alr Technologies to relaunch the GluCurve Pet CGM in January 2026. News release. ALR Technologies SG Ltd. December 8, 2025. Accessed December 8, 2025. https://prnmedia.prnewswire.com/news-releases/alr-technologies-to-relaunch-the-glucurve-pet-cgm-in-january-2026-302635427.html
2. McCafferty C. Transforming Veterinary Practice: The Latest in Glucose Monitoring Technology. Dvm360. October 2, 2025. Accessed December 8, 2025. https://www.dvm360.com/view/transforming-veterinary-practice-the-latest-in-glucose-monitoring-technology